Nuestros blogs explican las afecciones de salud y la investigación clínica de una manera fácil de entender, para que los lectores se sientan más informados.
More than 90% of the world’s children breathe toxic air every day
Every day around 93% of the world’s children under the age of 15 years (1.8 billion children) breathe air that is so polluted it puts their health and development at serious risk. Tragically, many of them die: WHO estimates that in...
Bijuva se convierte en la primera terapia hormonal aprobada por la FDA para el tratamiento de los sofocos.
TherapeuticsMD, Inc., a women’s healthcare company, has received FDA approval for Bijuva (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe...
A new way to prevent heart disease in Type 1 diabetes
Scientists reveal the mechanism which allows a commonly prescribed drug for Type 2 diabetes to prevent heart disease in patients with Type 1 diabetes and could lead to new treatments. Metformin is an inexpensive treatment that is often used for Type...
La FDA aprueba un nuevo medicamento para tratar la influenza.
Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for a Flu treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours. “This is the...
800 000 personas se suicidan cada año. ¿Qué podemos hacer?
By the time you finish reading this, at least six people will have killed themselves around the world. Those six are a tiny fraction of the 800,000 people who will kill themselves this year – more than the population of Washington DC,...
AbbVie Resolves Humira Patent Disputes with Sandoz
AbbVie and Novartis’ Sandoz unit reached a global resolution of all intellectual property-related litigation over Sandoz’s proposed biosimilar Hyrimoz for the reference drug Humira (adalimumab). Under the terms of the settlement, AbbVie has granted Sandoz a non-exclusive license to intellectual property relating to Humira beginning...
Near-Infrared Spectroscopy Could Improve Flu Vaccine Manufacturing
Recent research from North Carolina State University outlines how near-infrared (NIR) spectroscopy could be used to make cell-culture-based Flu Vaccine manufacturing faster and more efficient. The researchers demonstrated the use of a NIR probe to measure the concentration of influenza virus...
CRISPR Helps Produce Bigger, Healthier Tomatoes
Next-generation gene-editing techniques could help produce nutrient-rich crops that are bigger and provide higher yields. An international team of researchers has developed a new crop from a wild plant within a single generation by using the gene-editing tool CRISPR-Cas9 to introduce...
Breakthrough in Designing a Better Salmonella Vaccine
UC Davis researchers announce in the Proceedings of the National Academy of Sciences this week a breakthrough in understanding which cells afford optimal protection against Salmonella infection—a critical step in developing a more effective and safe vaccine against a bacterium that annually kills...
FDA Extends Acorda’s Inbrija NDA Review Period
Acorda Therapeutics, Inc. announced that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date for its review of the New Drug Application NDA of Inbrija (levodopa inhalation powder) from October 5, 2018, to January 5, 2019. This...
Predicting response to immunotherapy
At a Glance Three research teams working independently found that they may be able to predict which patients are most likely to respond to certain cancer treatments known as immune checkpoint therapies. These approaches may lead to lab tests that can...
Un estudio relaciona el fármaco azatioprina, de uso generalizado, con el cáncer de piel
A drug used to treat inflammatory bowel disease, arthritis, and vasculitis as well as to prevent organ rejection in transplant patients has been identified as an essential contributor to Skin Cancer development, in a research study carried out at the University...